Accessibility Statement Skip Navigation
  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing
  • Login
  • GDPR
  • Create a Free Account
Return to PRWeb homepage
  • News
  • Resources
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please change your search terms and try again.
  • News in Focus
      • Browse News Releases

      • All News Releases
      • Multimedia Gallery

      • All Multimedia
      • All Photos
      • All Videos
  • Business & Money
      • Auto & Transportation

      • Aerospace, Defense
      • Air Freight
      • Airlines & Aviation
      • Automotive
      • Maritime & Shipbuilding
      • Railroads and Intermodal Transportation
      • Supply Chain/Logistics
      • Transportation, Trucking & Railroad
      • Travel
      • Trucking and Road Transportation
      • View All Auto & Transportation

      • Business Technology

      • Blockchain
      • Broadcast Tech
      • Computer & Electronics
      • Computer Hardware
      • Computer Software
      • Data Analytics
      • Electronic Commerce
      • Electronic Components
      • Electronic Design Automation
      • Financial Technology
      • High Tech Security
      • Internet Technology
      • Nanotechnology
      • Networks
      • Peripherals
      • Semiconductors
      • View All Business Technology

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Financial Services & Investing

      • Accounting News & Issues
      • Acquisitions, Mergers and Takeovers
      • Banking & Financial Services
      • Bankruptcy
      • Bond & Stock Ratings
      • Conference Call Announcements
      • Contracts
      • Cryptocurrency
      • Dividends
      • Earnings
      • Earnings Forecasts & Projections
      • Financing Agreements
      • Insurance
      • Investments Opinions
      • Joint Ventures
      • Mutual Funds
      • Private Placement
      • Real Estate
      • Restructuring & Recapitalization
      • Sales Reports
      • Shareholder Activism
      • Shareholder Meetings
      • Stock Offering
      • Stock Split
      • Venture Capital
      • View All Financial Services & Investing

      • General Business

      • Awards
      • Commercial Real Estate
      • Corporate Expansion
      • Earnings
      • Environmental, Social and Governance (ESG)
      • Human Resource & Workforce Management
      • Licensing
      • New Products & Services
      • Obituaries
      • Outsourcing Businesses
      • Overseas Real Estate (non-US)
      • Personnel Announcements
      • Real Estate Transactions
      • Residential Real Estate
      • Small Business Services
      • Socially Responsible Investing
      • Surveys, Polls and Research
      • Trade Show News
      • View All General Business

  • Science & Tech
      • Consumer Technology

      • Artificial Intelligence
      • Blockchain
      • Cloud Computing/Internet of Things
      • Computer Electronics
      • Computer Hardware
      • Computer Software
      • Consumer Electronics
      • Cryptocurrency
      • Data Analytics
      • Electronic Commerce
      • Electronic Gaming
      • Financial Technology
      • Mobile Entertainment
      • Multimedia & Internet
      • Peripherals
      • Social Media
      • STEM (Science, Tech, Engineering, Math)
      • Supply Chain/Logistics
      • Wireless Communications
      • View All Consumer Technology

      • Energy & Natural Resources

      • Alternative Energies
      • Chemical
      • Electrical Utilities
      • Gas
      • General Manufacturing
      • Mining
      • Mining & Metals
      • Oil & Energy
      • Oil and Gas Discoveries
      • Utilities
      • Water Utilities
      • View All Energy & Natural Resources

      • Environ­ment

      • Conservation & Recycling
      • Environmental Issues
      • Environmental Policy
      • Environmental Products & Services
      • Green Technology
      • Natural Disasters
      • View All Environ­ment

      • Heavy Industry & Manufacturing

      • Aerospace & Defense
      • Agriculture
      • Chemical
      • Construction & Building
      • General Manufacturing
      • HVAC (Heating, Ventilation and Air-Conditioning)
      • Machinery
      • Machine Tools, Metalworking and Metallurgy
      • Mining
      • Mining & Metals
      • Paper, Forest Products & Containers
      • Precious Metals
      • Textiles
      • Tobacco
      • View All Heavy Industry & Manufacturing

      • Telecomm­unications

      • Carriers and Services
      • Mobile Entertainment
      • Networks
      • Peripherals
      • Telecommunications Equipment
      • Telecommunications Industry
      • VoIP (Voice over Internet Protocol)
      • Wireless Communications
      • View All Telecomm­unications

  • Lifestyle & Health
      • Consumer Products & Retail

      • Animals & Pets
      • Beers, Wines and Spirits
      • Beverages
      • Bridal Services
      • Cannabis
      • Cosmetics and Personal Care
      • Fashion
      • Food & Beverages
      • Furniture and Furnishings
      • Home Improvement
      • Household, Consumer & Cosmetics
      • Household Products
      • Jewelry
      • Non-Alcoholic Beverages
      • Office Products
      • Organic Food
      • Product Recalls
      • Restaurants
      • Retail
      • Supermarkets
      • Toys
      • View All Consumer Products & Retail

      • Entertain­ment & Media

      • Advertising
      • Art
      • Books
      • Entertainment
      • Film and Motion Picture
      • Magazines
      • Music
      • Publishing & Information Services
      • Radio & Podcast
      • Television
      • View All Entertain­ment & Media

      • Health

      • Biometrics
      • Biotechnology
      • Clinical Trials & Medical Discoveries
      • Dentistry
      • FDA Approval
      • Fitness/Wellness
      • Health Care & Hospitals
      • Health Insurance
      • Infection Control
      • International Medical Approval
      • Medical Equipment
      • Medical Pharmaceuticals
      • Mental Health
      • Pharmaceuticals
      • Supplementary Medicine
      • View All Health

      • Sports

      • General Sports
      • Outdoors, Camping & Hiking
      • Sporting Events
      • Sports Equipment & Accessories
      • View All Sports

      • Travel

      • Amusement Parks and Tourist Attractions
      • Gambling & Casinos
      • Hotels and Resorts
      • Leisure & Tourism
      • Outdoors, Camping & Hiking
      • Passenger Aviation
      • Travel Industry
      • View All Travel

  • Policy & Public Interest
      • Policy & Public Interest

      • Advocacy Group Opinion
      • Animal Welfare
      • Congressional & Presidential Campaigns
      • Corporate Social Responsibility
      • Domestic Policy
      • Economic News, Trends, Analysis
      • Education
      • Environmental
      • European Government
      • FDA Approval
      • Federal and State Legislation
      • Federal Executive Branch & Agency
      • Foreign Policy & International Affairs
      • Homeland Security
      • Labor & Union
      • Legal Issues
      • Natural Disasters
      • Not For Profit
      • Patent Law
      • Public Safety
      • Trade Policy
      • U.S. State Policy
      • View All Policy & Public Interest

  • People & Culture
      • People & Culture

      • Aboriginal, First Nations & Native American
      • African American
      • Asian American
      • Children
      • Diversity, Equity & Inclusion
      • Hispanic
      • Lesbian, Gay & Bisexual
      • Men's Interest
      • People with Disabilities
      • Religion
      • Senior Citizens
      • Veterans
      • Women
      • View All People & Culture

  • Hamburger menu
  • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
  • Create a Free Account
    • ALL CONTACT INFO
    • Contact Us


      11AM ET Sunday – 8PM ET Friday

  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • News in Focus
    • Browse All News
    • Multimedia Gallery
  • Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
  • Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
  • Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
  • Policy & Public Interest
  • People & Culture
    • People & Culture
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR
  • Send a Release
  • Sign up
  • Log in
  • Resources
  • RSS
  • GDPR

The American Association of Naturopathic Physicians to Urge Congressional Support for Protecting Patient Access to Compounded Medications

Despite a long history of safe use and patient need, the FDA has blocked patient access to ingredients used in compounded medications.


News provided by

American Association of Naturopathic Physicians

Jun 19, 2019, 17:00 ET

Share this article

Share toX

Share this article

Share toX


WASHINGTON, June 19, 2019 /PRNewswire-PRWeb/ -- The American Association of Naturopathic Physicians (AANP) recently hosted its annual DC Federal Legislative Initiative (DC FLI), June 8-10 at the Georgetown University Hotel & Conference Center. After a two day training, 150 licensed naturopathic doctors (NDs) and students descended on Capitol Hill to advocate on behalf of their patients for three priorities: Protecting Patient Access to Compounded Medications (H.R. 1959), the Mainstreaming Addiction Treatment (MAT) Act (H.R. 2482), and joining the Congressional Integrative Health & Wellness Caucus.

Despite a long history of safe use and patient need, the FDA has blocked patient access to ingredients used in compounded medications and is in the process of reviewing and potentially blocking access to more than 300 compounded ingredients needed and used by hundreds of thousands of patients. Many are herbal medicines or naturally occurring substances. Licensed naturopathic doctors know that compounded medications are necessary for patients with conditions that make them resistant to mass-produced medicine. They can be lifesaving for:
1.    Patients with allergies to common fillers and preservatives used to store and shelf mass-produced, commercially available drugs (lactose, gluten, or artificial dyes)
2.    Children and adults with digestive issues who are not able to take medication orally
3.    People who need customized dosage or strengths not available in mass-produced, commercially available drugs

Despite a long history of safe use and patient need, the FDA has blocked patient access to ingredients used in compounded medications and is in the process of reviewing and potentially blocking access to more than 300 compounded ingredients needed and used by hundreds of thousands of patients.

Post this

Many patients and physicians have expressed concern over FDA restrictions. "My cancer patients need access to these compounded medications to improve quality of life and the outcomes for their diseases," stated Eliot Edwards, ND, FABNO, and AANP board member.

In addition to preserving patient access to vital compounded medicines, the AANP urged Congress to sponsor H.R. 2482, the Mainstreaming Addiction Treatment Act. Because medical professionals need a special DEA waiver to prescribe buprenorphine to treat substance use disorder, this leads to treatment bottlenecks and a lack of providers. NDs are highly effective at treating pain with non-pharmacological approaches, and in several states also have authority to prescribe opioids and controlled substances in their scope of practice (OR, AZ, VT, CA). However, NDs are not currently eligible under federal law to apply for this DEA waiver. H.R. 2482 eliminates the redundant, outdated requirement that practitioners apply for a separate waiver to prescribe buprenorphine for substance use disorder treatment. If prescribing DEA Schedules III-V is in the scope of practice of naturopathic doctors as defined by state law, then they would be part of the solution to address America's opioid crisis.

Health care in the U.S. is almost entirely oriented to treating patients once they are ill – most often through costly prescription drugs, invasive surgeries, and hospitalization. The DC FLI highlights that patient health benefits from being able to access providers like licensed naturopathic doctors who focus on disease prevention, often through non-pharmacological treatment options grounded in nutrition, lifestyle, and patient-centered care to restore health. The AANP, through the DC FLI, is working to educate members of Congress about the role licensed Naturopathic Doctors play in providing safe, effective, and affordable health care. To this end, participants finished the day of lobbying with the AANP DC FLI Whole Health Reception, where participants demonstrate how food is a powerful medicine that plays a pivotal role in health.

In total, AANP DC FLI participants met with 80 Senate offices and 159 offices in the House of Representatives, resulting in 984 meetings (514 in the House and 470 in the Senate). These visits included meetings with the Chairs and Ranking Minority Members of the House Committee on Energy and Commerce, House Committee on Ways and Means, House Committee on Judiciary, and Senate Health, Education, Labor and Pensions (HELP) Committee.

###

About the AANP:
The American Association of Naturopathic Physicians (AANP) is the professional association that represents licensed naturopathic physicians. The AANP strives to make naturopathic medicine available to every American, and to increase recognition of naturopathic physicians as the identified authorities on natural medicine. Learn more at http://www.naturopathic.org.

SOURCE American Association of Naturopathic Physicians

Related Links

http://www.naturopathic.org

Modal title

What is the difference between a licensed naturopathic doctor and an unlicensed naturopath
View PDF
What is the difference between a licensed naturopathic doctor and an unlicensed naturopath
HR 2482 Bill Language
View PDF
HR 2482 Bill Language
DQSA 1959 Fact Sheet
View PDF
DQSA 1959 Fact Sheet
Congressional Support for Compounded Medications
View PDF
Congressional Support for Compounded Medications
Patient Testimonials for Compounded Medications
View PDF
Patient Testimonials for Compounded Medications
Joining the Integrative Health & Wellness Caucus
View PDF
Joining the Integrative Health & Wellness Caucus
What is the difference between a licensed naturopathic doctor and an unlicensed naturopath HR 2482 Bill Language DQSA 1959 Fact Sheet Congressional Support for Compounded Medications Patient Testimonials for Compounded Medications Joining the Integrative Health & Wellness Caucus

Contact PRWeb

  • 11AM ET Sunday – 8PM ET Friday
  • Contact Us

About PRWeb

  • About PRWeb
  • Partners
  • Partnership Programs
  • Editorial Guidelines
  • Resources

Why PRWeb

  • Why PRWeb
  • How It Works
  • Who Uses It
  • Pricing

Accounts

  • Create a Free Account
  • Log in
  • Contact Us

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921

Contact Cision

Products

About

My Services
  • All News Releases
  • Online Member Center
  • ProfNet
Cision Distribution Helpline
888-776-0942
  • Legal
  • Site Map
  • RSS
  • Cookie Settings
Copyright © 2025 Cision US Inc.